DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.

Bastien JametHatem NecibThomas CarlierEric FrampasJuliette BazinPaul-Henri DesfontisAurélien MonnetCaroline Bodet-MilinPhilippe MoreauCyrille TouzeauFrancoise Kraeber-Bodere

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2024)

Different DCE-MRI-based parameters (PEI, TPEI, MITR) could significantly differentiate all monoclonal plasma cell disease stages and complemented conventional MRI and PET-based biomarkers.

Keyphrases

contrast enhanced
diffusion weighted
computed tomography
magnetic resonance imaging
magnetic resonance
diffusion weighted imaging
positron emission tomography
pet ct
pet imaging
single cell
high resolution
multiple myeloma
bone marrow
fluorescence imaging